Aurinia Reports Third Quarter 2020 Financial Results and Recent Operational HighlightsBusiness Wire • 11/10/20
Aurinia Presents Integrated Time to Renal Response Data from the AURA-LV and AURORA Trials, along with Voclosporin Drug-Drug Interaction Data at ACR Convergence 2020Business Wire • 11/09/20
Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 11/05/20
Aurinia Announces European Investigator-Initiated Trial to Evaluate Antiviral Activity of Voclosporin in Kidney Transplant Recipients with COVID-19Business Wire • 10/27/20
Aurinia Presents Voclosporin Efficacy and Pharmacokinetic Data from Integrated Analysis of AURA-LV and AURORA Pivotal Trials at ASN Kidney Week 2020Business Wire • 10/22/20
Aurinia Pharmaceuticals: Down 30% From Its High, It Offers A Discounted De-Risked Multi-Billion Dollar OpportunitySeeking Alpha • 10/19/20
Aurinia: Ready For Voclosporin's Positive Jan. 2021 NDA Announcement, 45% UpsideSeeking Alpha • 10/14/20
Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, TimeIsNephrons.comBusiness Wire • 10/14/20
Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 10/02/20
Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye SyndromeBusiness Wire • 09/28/20
Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor ConferencesBusiness Wire • 09/10/20
Potential Positive Readout Of Aurinia Pharmaceuticals' Phase 2/3 AUDREY Trial Could Bring Best-In-Class Eye Drops For Dry Eye SyndromeSeeking Alpha • 09/08/20
Aurinia Pharmaceuticals, Inc.'s (AUPH) CEO Peter Greenleaf on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/12/20
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/11/20
Aurinia Reports Second Quarter 2020 Financial Results and Recent Operational HighlightsBusiness Wire • 08/11/20
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology ConferenceBusiness Wire • 08/04/20
Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020Business Wire • 07/30/20